Medtronic Touts Study of Accuracy, Cost Effectiveness of Capnography Monitors
Wednesday, October 28, 2015
Medtronic (NYSE:MDT) today presented data from 2 clinical studies of its capnography patient monitoring systems, touting their accuracy and cost-effectiveness.
Data from the studies was presented at the Anesthesiology 2015 annual meeting in San Diego this week.
“The findings presented today demonstrate the clinical benefits and potential cost savings capnography can provide across a broad spectrum of patients. These studies underscore Medtronic’s commitment to reducing the growing burden of respiratory compromise across clinical settings to improve the health and care of patients,” Medtronic minimally invasive therapies group medical chief Dr. Michael Tarnoff said in a press release.